MedTrace Logo

Predictive Value of Embryonic Testing

NCT03604107 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 237

Last updated 2022-01-14

No results posted yet for this study

Summary

The primary objective of this study is to determine the predictive value of preimplantation genetic screening (PGS) as a marker of embryonic competence. Secondary objectives are to define the related or independent predictive values of other proposed markers of embryonic and maternal reproductive competence in assisted reproductive technology (ART) cycles.

Conditions

Interventions

GENETIC

Preimplantation Genetic Testing-Aneuploidy

trophectoderm biopsy samples will be analyzed for karyotype after clinical outcome is determined

Sponsors & Collaborators

  • Reproductive Medicine Associates of New Jersey

    lead OTHER

Principal Investigators

  • Richard T Scott Jr., MD, HCLD · IVI RMA

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-30
Primary Completion
2020-09-30
Completion
2020-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03604107 on ClinicalTrials.gov